Millions of Canadians experience irregular heart rhythms, known as arrhythmias. Arrhythmias can cause sudden cardiac death, which kills 40,000 Canadians a year. Arrhythmias are projected to be the leading cause of death in Canada by 2020.
As part of the federal government’s Networks of Centres of Excellence (NCE) program, CANet is a multidisciplinary, multi-sectoral research and development network of over 100 investigators, well-positioned industry partners, patients and healthcare providers focused on arrhythmia research and commercialization activities.
At the core of CANet’s success are our connections with our researchers, our trainees, and our fully-engaged patients and partners.
CANet is harnessing the talents of the best arrhythmia researchers, engineers and social scientists in Canada with an end goal of making new discoveries and transforming them into products, services, and improved processes to achieve national and global impact. Together, we are working towards the future, which is shaped by a clear vision: a transformed Canadian arrhythmia care ecosystem focused on the individual needs of each patient.
Learn more about who we are, click here.
With our vision for access for all Canadians to early detection, effective prevention, efficient and timely treatment of arrhythmia and related conditions, through a transformed, patient-driven care model, our Network is committed to working with members including patients, investigators, and trainees across all provinces.
CANet continues to move aggressively towards the achievement of the goals outlined in our Strategic Plan and position Canada not only as the leader in arrhythmia research and patient engagement but as a world leader at the forefront of the healthcare sector.
Learn more about who we are, our goals, and the impacts we’re making, click here.